Acadia Healthcare Company Inc (NASDAQ:ACHC) was the target of some unusual options trading activity on Tuesday. Stock investors purchased 960 call options on the company. This represents an increase of approximately 1,400% compared to the typical volume of 64 call options.
In related news, Director Reeve B. Waud sold 100,000 shares of the firm’s stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $31.80, for a total value of $3,180,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 11.10% of the stock is owned by company insiders.
A number of institutional investors have recently added to or reduced their stakes in ACHC. Janus Henderson Group PLC acquired a new stake in shares of Acadia Healthcare during the 2nd quarter worth approximately $74,805,000. State Street Corp grew its position in shares of Acadia Healthcare by 95.2% during the 2nd quarter. State Street Corp now owns 1,998,030 shares of the company’s stock worth $98,667,000 after buying an additional 974,524 shares during the period. Dimensional Fund Advisors LP grew its position in shares of Acadia Healthcare by 107.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,486,643 shares of the company’s stock worth $73,412,000 after buying an additional 769,333 shares during the period. Vanguard Group Inc. grew its position in shares of Acadia Healthcare by 8.9% during the 2nd quarter. Vanguard Group Inc. now owns 6,254,532 shares of the company’s stock worth $308,849,000 after buying an additional 511,299 shares during the period. Finally, Frontier Capital Management Co. LLC grew its position in shares of Acadia Healthcare by 13.2% during the 4th quarter. Frontier Capital Management Co. LLC now owns 2,903,403 shares of the company’s stock worth $94,738,000 after buying an additional 337,961 shares during the period.
Acadia Healthcare (NASDAQ:ACHC) opened at $34.02 on Friday. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 1.30. Acadia Healthcare has a fifty-two week low of $26.92 and a fifty-two week high of $54.34. The stock has a market cap of $3,009.86, a P/E ratio of 17.72, a price-to-earnings-growth ratio of 1.16 and a beta of 0.85.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.